Clinical Trials in Nashville

Showing 6441-6460 of 15,379 trials

Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer

NCT01126736

The purpose of this study is to determine whether Eribulin Mesylate Administered in Combination with Pemetrexed is safe and tolerable and to gain a preliminary indication of clinical benefit when administered to Patients with Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer.

Non Small Cell Lung Cancer

Eisai Inc.98 participantsStarted Jun 2010

Tucson, Arizona, United States • Denver, Colorado, United States • Fort Myers, Florida, United States +15 more locations

COMPLETEDPhase 1< 1 mile

Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed

NCT00003649

RATIONALE: Exposing tumor cells to the p53 gene may improve the body's ability to fight non-small cell lung cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy in treating patients who have non-small cell lung cancer that cannot be surgically removed.

Lung Cancer

Eastern Cooperative Oncology GroupStarted Nov 1998

Nashville, Tennessee, United States • Nashville, Tennessee, United States • Green Bay, Wisconsin, United States

Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer

Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Find Trials by Condition in Nashville

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer

Study of MT-5111 in HER2-positive Solid Tumors

Treatment of Moderate to Severe Glabellar Lines

Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.

A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)

Clinical Performance of Senofilcon A Investigational Lens

Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression

Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2)

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Treatment of Moderate to Severe Lateral Canthal Lines

Transnasal Induction of Normothermia in Febrile Stroke Patients

A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1)